On Monday, Cogent Biosciences Inc (NASDAQ: COGT) was -7.56% drop from the session before settling in for the closing price of $6.48. A 52-week range for COGT has been $5.88 – $12.61.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -33.00% over the last five years. When this article was written, the company’s average yearly earnings per share was at 9.38%. With a float of $95.39 million, this company’s outstanding shares have now reached $110.46 million.
The firm has a total of 205 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Cogent Biosciences Inc (COGT) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Cogent Biosciences Inc stocks. The insider ownership of Cogent Biosciences Inc is 16.22%, while institutional ownership is 91.52%. The most recent insider transaction that took place on Jan 14 ’25, was worth 332,412. In this transaction Chief Commercial Officer of this company bought 43,750 shares at a rate of $7.60, taking the stock ownership to the 45,848 shares.
Cogent Biosciences Inc (COGT) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.38% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.60% during the next five years compared to 10.02% growth over the previous five years of trading.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
You can see what Cogent Biosciences Inc (COGT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.47, a number that is poised to hit -0.58 in the next quarter and is forecasted to reach -1.87 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Analysing the last 5-days average volume posted by the [Cogent Biosciences Inc, COGT], we can find that recorded value of 1.71 million was better than the volume posted last year of 1.37 million. As of the previous 9 days, the stock’s Stochastic %D was 15.36%. Additionally, its Average True Range was 0.47.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 1.58%, which indicates a significant decrease from 5.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.26% in the past 14 days, which was lower than the 66.73% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.83, while its 200-day Moving Average is $9.17. Now, the first resistance to watch is $6.32. This is followed by the second major resistance level at $6.66. The third major resistance level sits at $6.87. If the price goes on to break the first support level at $5.77, it is likely to go to the next support level at $5.56. Now, if the price goes above the second support level, the third support stands at $5.22.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
There are 113,850K outstanding shares of the company, which has a market capitalization of 681.96 million. As of now, sales total 0 K while income totals -255,860 K. Its latest quarter income was 0 K while its last quarter net income were -67,930 K.
